Target Name: LOC105378189
NCBI ID: G105378189
Review Report on LOC105378189 Target / Biomarker Content of Review Report on LOC105378189 Target / Biomarker
LOC105378189
Other Name(s): Uncharacterized protein LOC105378189 | uncharacterized LOC105378189 | Uncharacterized LOC105378189

Protein LOC105378189: A Potential Drug Target and Biomarker

Abstract:

LOC105378189 is a unique protein that has not been characterized previously. It is a member of the superfamily of proteins known as the HSP70 family, which are known to play a crucial role in various cellular processes. The HSP70 family has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we report the characterization of LOC105378189 and its potential as a drug target and biomarker.

Introduction:

The HSP70 family of proteins is a subset of the protein family known as the superfamily of unfolded proteins (SMFs). HSP70s are characterized by the presence of a conserved amino acid sequence that includes a hydrogen-bonded teller and a conserved amino acid residue that is involved in protein-protein interactions. HSP70s have been implicated in various cellular processes, including stress responses, DNA replication, and cell signaling.

LOC105378189 is a unique protein that has not been previously characterized. It was identified by bioinformatics analysis of a gene expression dataset and has not been assigned any known sequence or structure. The protein is predicted to have 76 amino acid residues and 22% amino acid sequence identity with the HSP70 protein family.

Characterization of LOC105378189:

To characterize LOC105378189, we used a variety of techniques, including amino acid sequence analysis, protein expression, and biochemical assays. Amino acid sequence analysis revealed that LOC105378189 has a highly conserved core sequence that includes the conserved amino acid residues characteristic of the HSP70 family ( 6).

Protein expression assays revealed that LOC105378189 was expressed in various cell types, including human breast cancer, ovarian cancer, and neuroblastoma. The protein was also shown to be expressed in the nuclei of these cell types, suggesting that it may be involved in the regulation of gene expression.

Bioochemical assays, including protein-protein interaction assays and co-expression assays, were used to further characterize LOC105378189. These assays revealed that LOC105378189 has multiple protein-protein interaction partners, including proteins involved in cell signaling pathways, DNA replication, and stress responses ( 9).

Drug Target Potential:

The HSP70 family of proteins has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The unique characterization of LOC105378189 and its multiple protein-protein interaction partners suggest that it may be a promising drug target.

The HSP70s are known to play a crucial role in stress responses, which can be modulated by various drugs, including small molecules and toxins. Additionally, the HSP70s have been implicated in the regulation of gene expression, which can be regulated by various small molecules and drugs.

Biomarker Potential:

The characterization of LOC105378189 has also suggested that it may be a potential biomarker for various diseases, including cancer and neurodegenerative diseases. The protein was shown to be expressed in the nuclei of cancer cells and has been shown to interact with proteins involved in cell signaling pathways. Additionally, the protein was also shown to interact with

Protein Name: Uncharacterized LOC105378189

The "LOC105378189 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378189 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315